Smith J - Search Results

1

Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study.

Safdar N, Smith J, Knasinski V, Sherkow C, Herrforth C, Knechtle S, Andes D. Safdar N, et al. Among authors: smith j. Diagn Microbiol Infect Dis. 2010 Jan;66(1):7-15. doi: 10.1016/j.diagmicrobio.2009.08.017. Diagn Microbiol Infect Dis. 2010. PMID: 19963164

2

Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.

Smith J, Andes D. Smith J, et al. Ther Drug Monit. 2008 Apr;30(2):167-72. doi: 10.1097/FTD.0b013e318167d0e0. Ther Drug Monit. 2008. PMID: 18367976 Review.

3

Fosfomycin for the Treatment of Cystitis in the Abdominal Solid Organ Transplant Population.

Loethen AA, Kerstenetzky L, Descourouez JL, Leverson GE, Smith JA, Jorgenson MR. Loethen AA, et al. Pharmacotherapy. 2017 May;37(5):599-606. doi: 10.1002/phar.1924. Epub 2017 Apr 17. Pharmacotherapy. 2017. PMID: 28295441

4

Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal Dysfunction.

Kerstenetzky L, Jorgenson MR, Descourouez JL, Leverson G, Rose WE, Redfield RR, Smith JA. Kerstenetzky L, et al. Ann Pharmacother. 2017 Sep;51(9):751-756. doi: 10.1177/1060028017710252. Epub 2017 May 16. Ann Pharmacother. 2017. PMID: 28511545

5

Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients.

Splinter LE, Kerstenetzky L, Jorgenson MR, Descourouez JL, Leverson GE, Saddler CM, Smith JA, Safdar N, Redfield RR. Splinter LE, et al. Ann Pharmacother. 2018 Feb;52(2):113-119. doi: 10.1177/1060028017727756. Epub 2017 Aug 26. Ann Pharmacother. 2018. PMID: 28844154

6

The feared five fungal infections in kidney transplant recipients: A single-center 20-year experience.

Parajuli S, Wick A, Pandeya S, Astor BC, Smith J, Djamali A, Mandelbrot DA. Parajuli S, et al. Among authors: smith j. Clin Transplant. 2018 Jul;32(7):e13289. doi: 10.1111/ctr.13289. Epub 2018 Jun 19. Clin Transplant. 2018. PMID: 29782660 Clinical Trial.

7

Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.

Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM, Smith JA, Mandelbrot DA. Jorgenson MR, et al. Transpl Infect Dis. 2019 Jun;21(3):e13080. doi: 10.1111/tid.13080. Epub 2019 Apr 16. Transpl Infect Dis. 2019. PMID: 30891915

8

Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients.

Jorgenson MR, Descourouez JL, Yang DY, Leverson GE, Saddler CM, Smith JA, Safdar N, Mandlebrot DA, Redfield RR. Jorgenson MR, et al. Ann Pharmacother. 2019 Oct;53(10):1020-1025. doi: 10.1177/1060028019845003. Epub 2019 Apr 21. Ann Pharmacother. 2019. PMID: 31007034

9

The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.

Jorgenson MR, Descourouez JL, Lyu B, Astor BC, Garg N, Smith JA, Mandelbrot DA. Jorgenson MR, et al. Clin Transplant. 2019 Aug;33(8):e13636. doi: 10.1111/ctr.13636. Epub 2019 Jul 1. Clin Transplant. 2019. PMID: 31194887

10

Evaluation of infectious risk and outcomes in the hmong renal transplant population.

Jorgenson MR, Cardinale B, Descourouez JL, Yang DY, Leverson GE, Parajuli S, Smith JA, Redfield RR. Jorgenson MR, et al. Transpl Infect Dis. 2019 Oct;21(5):e13142. doi: 10.1111/tid.13142. Epub 2019 Jul 22. Transpl Infect Dis. 2019. PMID: 31283867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,552 results

Search Page

Filters